统一痉挛性发声障碍评定量表在内收型喉部肌张力障碍中的应用价值
结果显示USDRS变异度显著低于其他指标,与VHI-10、总体严重度和紧张度呈正相关,但未提供额外信息,可能限制其用于监测治疗反应。
要点
- USDRS变异度显著低于患者报告结局、CAPE-V和声学分析。
- USDRS与VHI-10、总体严重度、紧张度呈正相关。
- USDRS未提供超出已有指标的信息,监测治疗反应价值有限。
核心结论
- USDRS变异度受限,未超越VHI-10、CAPE-V和CPP-S提供额外信息,可能不适用于监测内收型喉部肌张力障碍的治疗反应。
主要发现
- USDRS的变异度显著低于所有其他临床医生报告、患者报告结局及声学分析。
- USDRS总分与VHI-10呈正相关(R=0.451,p=0.002)。
- USDRS总分与总体严重度呈正相关(R=0.482,p=0.004),与紧张度呈正相关(R=0.487,p=0.004)。
关键数值与推荐
- USDRS与VHI-10相关系数R=0.451(p=0.002)。
- USDRS与总体严重度相关系数R=0.482(p=0.004)。
- USDRS与紧张度相关系数R=0.487(p=0.004)。
临床怎么用
- 在评估内收型喉部肌张力障碍时,USDRS可能不如VHI-10、CAPE-V和CPP-S敏感,临床监测治疗反应宜优先使用这些指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Unified Spasmodic Dysphonia Rating Scale (USDRS) was developed in 1997 to standardize evaluation of adductor-type laryngeal dystonia (AdLD) but has been sparsely utilized since then. The goal of this study was to explore the descriptive value and contemporary relevance of the USDRS in characterizing AdLD by examining its relationships with established patient-reported, clinician-perceptual, and acoustic measures. METHODS: Patients with stable-dose, botulinum toxin-A (BtxA)-responsive AdLD presented to a tertiary laryngology center for follow-up BtxA injections. USDRS, PROMs (Voice Handicap Index-10, Dyspnea Index, OMNI-Vocal Effort Scale, and Communicative Participation Item Bank-10), and voice recordings were obtained. Acoustic analysis was completed, and voice-specialized speech-language pathologists blindly rated voices using the Consensus Auditory Perceptual Evaluation-Voice (CAPE-V). Descriptive statistics compared each measurement with USDRS results. RESULTS: Forty-four patients (mean age 58.4 years) were evaluated in this study. The USDRS demonstrated significantly lower variance than all other clinician- and patient-reported outcomes as well as acoustic analysis. Comparison of overall USDRS score to other outcome measures demonstrated statistically significant, positive correlations: USDRS versus VHI-10 (R = 0.451, p = 0.002), Overall Severity (R = 0.482, p = 0.004), and Strain (R = 0.487, p = 0.004), respectively. CONCLUSIONS: The USDRS exhibited restricted variability relative to VHI-10, CAPE-V, and CPP-S and did not appear to add information beyond these measures; therefore, it may be limited for monitoring treatment response in AdLD patients.
引用
- Marshall CR, Schneider SL, Yang ST, et al. Utility of Unified Spasmodic Dysphonia Rating Scale for Adductor Type Laryngeal Dystonia (AdLD). Laryngoscope. 2026. PMID: 41786653. doi:10.1002/lary.70471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。